tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EXEL Stock Latest News

Exelixis reports Q1 adjusted EPS 62c, consensus 44c
The FlyExelixis reports Q1 adjusted EPS 62c, consensus 44c
2h ago
EXEL
Exelixis raises FY25 revenue view to $2.25B-$2.35B from $2.15B-$2.25B
PremiumThe Fly
Exelixis raises FY25 revenue view to $2.25B-$2.35B from $2.15B-$2.25B
2h ago
EXEL
Exelixis options imply 5.9% move in share price post-earnings
PremiumThe Fly
Exelixis options imply 5.9% move in share price post-earnings
3h ago
EXEL
Options Volatility and Implied Earnings Moves Today, May 13, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, May 13, 2025
11h ago
JD
NU
EXEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
EXEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
EXEL
Truist biotech analyst holds an analyst/industry conference call
PremiumThe FlyTruist biotech analyst holds an analyst/industry conference call
27d ago
BCAX
EXEL
Exelixis Launches Special Equity Award Program
Premium
Company Announcements
Exelixis Launches Special Equity Award Program
1M ago
8K
EXEL
Exelixis’s Strategic Positioning and sNDA Approval for Cabometyx Drive Buy Rating
Premium
Ratings
Exelixis’s Strategic Positioning and sNDA Approval for Cabometyx Drive Buy Rating
2M ago
EXEL
Exelixis Buy Rating: FDA Approval of Cabozantinib and Growth Catalysts Drive Positive Outlook
PremiumRatings
Exelixis Buy Rating: FDA Approval of Cabozantinib and Growth Catalysts Drive Positive Outlook
2M ago
EXEL
Exelixis Gains Buy Rating from Silvan Tuerkcan Following Early FDA Approval and Growth Potential in Neuroendocrine Tumor Market
PremiumRatings
Exelixis Gains Buy Rating from Silvan Tuerkcan Following Early FDA Approval and Growth Potential in Neuroendocrine Tumor Market
2M ago
EXEL
Exelixis’ cabozantinib approval ‘certainly positive,’ says Citi
PremiumThe Fly
Exelixis’ cabozantinib approval ‘certainly positive,’ says Citi
2M ago
EXEL
Exelixis announces FDA approval of Cabometyx treatment groups
PremiumThe Fly
Exelixis announces FDA approval of Cabometyx treatment groups
2M ago
EXEL
FDA approves cabozantinib for adults and pediatric patients with pNET and epNET
PremiumThe FlyFDA approves cabozantinib for adults and pediatric patients with pNET and epNET
2M ago
EXEL
Exelixis to present positive preclinical data across pipeline portfolio at AACR
Premium
The Fly
Exelixis to present positive preclinical data across pipeline portfolio at AACR
2M ago
EXEL
Exelixis price target raised to $40 from $38 at RBC Capital
Premium
The Fly
Exelixis price target raised to $40 from $38 at RBC Capital
2M ago
EXEL
Wells Fargo downgrades Exelixis, says take profits after rally
PremiumThe Fly
Wells Fargo downgrades Exelixis, says take profits after rally
3M ago
EXEL
Exelixis downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Exelixis downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
EXEL
Exelixis announces final five-year follow-up results from CheckMate -9ER
PremiumThe Fly
Exelixis announces final five-year follow-up results from CheckMate -9ER
3M ago
EXEL
Exelixis Hold Rating Maintained Amidst Stable Financials and Awaited Trial Data
PremiumRatings
Exelixis Hold Rating Maintained Amidst Stable Financials and Awaited Trial Data
3M ago
EXEL
Exelixis Earnings Call: Positive Growth and Ambitious Goals
PremiumCompany AnnouncementsExelixis Earnings Call: Positive Growth and Ambitious Goals
3M ago
EXEL
Exelixis price target raised to $38 from $34 at TD Cowen
Premium
The Fly
Exelixis price target raised to $38 from $34 at TD Cowen
3M ago
EXEL
Exelixis price target raised to $36 from $30 at Stifel
Premium
The Fly
Exelixis price target raised to $36 from $30 at Stifel
3M ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >